TY - JOUR
T1 - Midline brain structures in patients with current and remitted major depression
AU - Takahashi, Tsutomu
AU - Yücel, Murat
AU - Lorenzetti, Valentina
AU - Nakamura, Kazue
AU - Whittle, Sarah
AU - Walterfang, Mark
AU - Suzuki, Michio
AU - Pantelis, Christos
AU - Allen, Nicholas B.
N1 - Funding Information:
This research was supported by a grant from the Australian Research Council (I.D. DP0557663) awarded to A/Prof. Allen and A/Prof. Yücel. Neuroimaging analysis was facilitated by the Neuropsychiatry Imaging Laboratory managed by Ms. Bridget Soulsby at the Melbourne Neuropsychiatry Centre and supported by Neurosciences Victoria. The authors thank Ms. Orli Schwartz and Ms. Diana Maud for recruitment and assessment of the participants. A/Prof. Yücel is supported by an NHMRC Clinical Career Development Award (I.D. 509345). Ms. Lorenzetti is supported by a scholarship of the Faculty of Psychology, The University of Bologna, Italy. Dr. Walterfang was supported by a Pfizer Neuroscience Research Grant and a Stanley Research Centre Grant. Dr. Whittle was supported by an Australian Research Council Postdoctoral Fellowship. Dr. Takahashi was supported to undertake this work by a Grant-in-Aid for Scientific Research (No. 19591346) from the Japanese Society for the Promotion of Science; and a Research Grant (17-2,18-6) for Nervous and Mental Disorders from the Ministry of Health and Welfare (Dr. Suzuki), Japan. A/Prof. Allen is supported by a grant from the Colonial Foundation.
PY - 2009/8/31
Y1 - 2009/8/31
N2 - Brain morphologic changes of limbic-cortical regions have been reported in major depressive disorder (MDD). However, it remains largely unknown whether MDD is associated with abnormalities in midline brain structures, which play a critical role in limbic-cortical connectivity, and whether such changes reflect state or trait markers of the disorder. We used magnetic resonance imaging to investigate the length of the adhesio interthalamica (AI) and cavum septum pellucidum (CSP) in 29 currently depressed patients, 27 remitted depressed patients, and 33 age- and gender-matched healthy control subjects. The currently depressed patients had a significantly shorter AI compared with controls, but there was no difference in the AI length between the remitted patients and controls. The AI length in the overall patient group was negatively correlated with the severity of symptoms of "loss of interest" at the time of scanning. Furthermore, the patients with co-morbid anxiety disorders tended to have a shorter AI compared with those without. The CSP length and prevalence of a large CSP (≥ 6 mm) did not differ between the groups. Although a comprehensive investigation of medication effects was not possible due to incomplete medication data, these findings suggest that a shorter length of the AI may be associated with state-related brain changes in major depression rather than a stable marker of illness vulnerability. Whether the AI length exhibits ongoing changes across the course of the illness remains to be determined in longitudinal studies.
AB - Brain morphologic changes of limbic-cortical regions have been reported in major depressive disorder (MDD). However, it remains largely unknown whether MDD is associated with abnormalities in midline brain structures, which play a critical role in limbic-cortical connectivity, and whether such changes reflect state or trait markers of the disorder. We used magnetic resonance imaging to investigate the length of the adhesio interthalamica (AI) and cavum septum pellucidum (CSP) in 29 currently depressed patients, 27 remitted depressed patients, and 33 age- and gender-matched healthy control subjects. The currently depressed patients had a significantly shorter AI compared with controls, but there was no difference in the AI length between the remitted patients and controls. The AI length in the overall patient group was negatively correlated with the severity of symptoms of "loss of interest" at the time of scanning. Furthermore, the patients with co-morbid anxiety disorders tended to have a shorter AI compared with those without. The CSP length and prevalence of a large CSP (≥ 6 mm) did not differ between the groups. Although a comprehensive investigation of medication effects was not possible due to incomplete medication data, these findings suggest that a shorter length of the AI may be associated with state-related brain changes in major depression rather than a stable marker of illness vulnerability. Whether the AI length exhibits ongoing changes across the course of the illness remains to be determined in longitudinal studies.
KW - Adhesio interthalamica
KW - Cavum septum pellucidum
KW - Depression
KW - State factors
KW - Trait factors
UR - http://www.scopus.com/inward/record.url?scp=67651111824&partnerID=8YFLogxK
U2 - 10.1016/j.pnpbp.2009.05.020
DO - 10.1016/j.pnpbp.2009.05.020
M3 - 学術論文
C2 - 19505522
AN - SCOPUS:67651111824
SN - 0278-5846
VL - 33
SP - 1058
EP - 1063
JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry
JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry
IS - 6
ER -